Android app on Google Play

Oppenheimer Maintains an 'Outperform' on Humana (HUM); Reducing Numbers After Q2 Report

July 31, 2012 9:59 AM EDT Send to a Friend
Get Alerts HUM Hot Sheet
Price: $130.29 --0%

Rating Summary:
    7 Buy, 11 Hold, 3 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 3 | Down: 1 | New: 13
Trade HUM Now!
Join SI Premium – FREE
Oppenheimer maintains an 'Outperform' on Humana (NYSE: HUM) price target of $83.00 (from $98.00).

Analyst, Bret Jones, said, "While 2Q12 results were ahead of the company's expectations, it reduced its 2H12 outlook due to lower margins on the rapidly growing new member population ($170M) and higher cost trend across its entire book ($100M). It believes that all but a portion of the higher costs were captured in its FY2013 bids, which were submitted in June. Due to the lower guidance and increased uncertainty, we are lowering our FY2012 (ex-$0.18/share in legal costs) and FY2013 EPS estimates to $7.11 and $7.52 from $7.80 and $8.42."

For an analyst ratings summary and ratings history on Humana click here. For more ratings news on Humana click here.

Shares of Humana closed at $70.55 yesterday.




You May Also Be Interested In


Related Categories

Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT Change

Add Your Comment